Science Applications International Corp
Financial highlights
| Metric | FY 01/30/26 | FY 01/31/25 | FY 02/02/24 | FY 02/03/23 | FY 01/28/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.3B | $7.5B | $7.4B | $7.7B | $7.4B |
| Cost of revenue | $6.4B | $6.6B | $6.6B | $6.8B | $6.5B |
| Selling, general & administrative | $350.0M | $339.0M | $373.0M | $374.0M | $344.0M |
| Research and development | $13.0M | $12.0M | $4.0M | $1.0M | $4.0M |
| Operating income | $521.0M | $563.0M | $741.0M | $501.0M | $462.0M |
| Interest expense | — | — | — | $120.0M | $105.0M |
| Pretax income | $387.0M | $428.0M | $620.0M | $375.0M | $358.0M |
| Income tax expense | $29.0M | $66.0M | $143.0M | $72.0M | $79.0M |
| Net income | $358.0M | $362.0M | $477.0M | $300.0M | $277.0M |
| Balance Sheet | |||||
| Cash and equivalents | $182.0M | $56.0M | $94.0M | $109.0M | $106.0M |
| Current assets | $1.2B | $1.2B | $1.1B | $1.2B | $1.3B |
| Total assets | $5.4B | $5.2B | $5.3B | $5.5B | $5.7B |
| Current liabilities | $982.0M | $1.4B | $1.2B | $1.1B | $1.4B |
| Total debt | $2.5B | $2.2B | $2.1B | $2.4B | $2.5B |
| Stockholders' equity | $1.5B | $1.6B | $1.8B | $1.7B | $1.6B |
| Cash Flow Statement | |||||
| Cash from operations | $609.0M | $494.0M | $396.0M | $532.0M | $518.0M |
| Depreciation and amortization | $30.0M | $25.0M | $26.0M | $32.0M | $37.0M |
| Stock-based compensation | $64.0M | $53.0M | $68.0M | $48.0M | $46.0M |
| Capital expenditure | $32.0M | $36.0M | $27.0M | $25.0M | $36.0M |
| Free cash flow | $577.0M | $458.0M | $369.0M | $507.0M | $482.0M |
| Dividends paid | $70.0M | $75.0M | $79.0M | $83.0M | $86.0M |
| Share repurchases | $445.0M | $558.0M | $382.0M | $267.0M | $226.0M |
| Impairments | $1.0M | $0 | $0 | $4.0M | $18.0M |
Shares outstanding 42.3M · Free float 56.9%
Annual filing data through FY ended January 30, 2026; float as of July 14, 2026.